CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Shionogi & Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Shionogi & Co Ltd
3-1-8, Dosho-machi, Chuo-ku
Phone: +81 662022161p:+81 662022161 OSAKA-SHI, OSK  541-0045  Japan Ticker: 45074507
Business Summary
Shionogi & Co Ltd is a Japan-based company mainly engaged in the pharmaceutical business. The Company is mainly engaged in the research and development, purchasing, manufacturing, sales, and related activities of ethical pharmaceuticals. The Company is engaged in research and development, purchasing, manufacturing, and marketing of pharmaceuticals for the treatment of gram-negative bacterial infections, influenza virus infections, new coronavirus infections, invasive aspergillus infections, complicated urinary tract infections including pyelonephritis, Alzheimer's disease, chronic pain, cancer of the esophagus, bladder, head and neck, solid tumors, and other diseases. The Company provides products and services in Japan, Europe, North America, and other regions.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20243/31/2024Yes---Yes

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President, Chief Executive Officer, Representative Director IsaoTeshirogi 64 7/1/2022 4/1/2007
Vice Chairman of the Board TakukoSawada 69 7/1/2022 4/1/2011
Director KojiHanasaki 63 6/1/2025 4/1/2012
11 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
C & O Pharmaceutical Tech (Holdings) Ltd 911-12 Silvercord Tower 2 30 Canton Road Kowloon Hong Kong
Sciele Pharma Inc. Five Concourse Parkway Atlanta GA United States

Business Names
Business Name
4507
C & O Pharmaceutical Tech (Holdings) Ltd
Nichia Pharmaceutical Industries Ltd.
8 additional Business Names available in full report.

General Information
Number of Employees: 4,959 (As of 3/31/2024)
Outstanding Shares: 850,685,601 (As of 12/31/2024)
Shareholders: 56,112
Stock Exchange: TYO
Fax Number: +81 662299596


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, April 8, 2025